[HTML][HTML] PI3K/Akt/mTOR pathway and its role in cancer therapeutics: are we making headway?
Y Peng, Y Wang, C Zhou, W Mei, C Zeng - Frontiers in oncology, 2022 - frontiersin.org
Cancer is a severe public health issue that is a leading cause of mortality globally. It is also
an impediment to improving life expectancy worldwide. Furthermore, the global burden of …
an impediment to improving life expectancy worldwide. Furthermore, the global burden of …
Computational network biology: data, models, and applications
Biological entities are involved in intricate and complex interactions, in which uncovering the
biological information from the network concepts are of great significance. Benefiting from …
biological information from the network concepts are of great significance. Benefiting from …
Accurate and efficient detection of gene fusions from RNA sequencing data
S Uhrig, J Ellermann, T Walther, P Burkhardt… - Genome …, 2021 - genome.cshlp.org
The identification of gene fusions from RNA sequencing data is a routine task in cancer
research and precision oncology. However, despite the availability of many computational …
research and precision oncology. However, despite the availability of many computational …
[HTML][HTML] Fulvestrant plus capivasertib versus placebo after relapse or progression on an aromatase inhibitor in metastatic, oestrogen receptor-positive, HER2-negative …
Background Capivasertib, an AKT inhibitor, added to fulvestrant, was previously reported to
improve progression-free survival in women with aromatase inhibitor-resistant oestrogen …
improve progression-free survival in women with aromatase inhibitor-resistant oestrogen …
[HTML][HTML] The cuproptosis-related signature associated with the tumor environment and prognosis of patients with glioma
W Wang, Z Lu, M Wang, Z Liu, B Wu, C Yang… - Frontiers in …, 2022 - frontiersin.org
Background Copper ions are essential for cellular physiology. Cuproptosis is a novel
method of copper-dependent cell death, and the cuproptosis-based signature for glioma …
method of copper-dependent cell death, and the cuproptosis-based signature for glioma …
[HTML][HTML] Comprehensive characterization of cancer driver genes and mutations
Identifying molecular cancer drivers is critical for precision oncology. Multiple advanced
algorithms to identify drivers now exist, but systematic attempts to combine and optimize …
algorithms to identify drivers now exist, but systematic attempts to combine and optimize …
[HTML][HTML] Integrative multi-omic cancer profiling reveals DNA methylation patterns associated with therapeutic vulnerability and cell-of-origin
DNA methylation plays a critical role in establishing and maintaining cellular identity.
However, it is frequently dysregulated during tumor development and is closely intertwined …
However, it is frequently dysregulated during tumor development and is closely intertwined …
Oncogenic activation of the STAT3 pathway drives PD-L1 expression in natural killer/T-cell lymphoma
TL Song, ML Nairismägi, Y Laurensia… - Blood, The Journal …, 2018 - ashpublications.org
Mature T-cell lymphomas, including peripheral T-cell lymphoma (PTCL) and extranodal
NK/T-cell lymphoma (NKTL), represent a heterogeneous group of non-Hodgkin lymphomas …
NK/T-cell lymphoma (NKTL), represent a heterogeneous group of non-Hodgkin lymphomas …
Glioblastoma mutations alter EGFR dimer structure to prevent ligand bias
The epidermal growth factor receptor (EGFR) is frequently mutated in human cancer,, and is
an important therapeutic target. EGFR inhibitors have been successful in lung cancer, where …
an important therapeutic target. EGFR inhibitors have been successful in lung cancer, where …
PIK3CA variants selectively initiate brain hyperactivity during gliomagenesis
Glioblastoma is a universally lethal form of brain cancer that exhibits an array of
pathophysiological phenotypes, many of which are mediated by interactions with the …
pathophysiological phenotypes, many of which are mediated by interactions with the …